Y-Intercept (HK)’s Axcelis ACLS Stock Holding History

Y-Intercept (HK)’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,091	Closed	-$660K	–	1317
2023 Q4	$660K	Buy	5,091 +406	+9%	+$56K	0.06%	476
2023 Q3	$764K	Buy	+4,685	New	+$824K	0.07%	402

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Y-Intercept (HK)'s ACLS Position: Q1 2024 in Review

Y-Intercept (HK) sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 5,091 shares — an estimated $660K sold.

Y-Intercept (HK) first reported a position in ACLS in Q3 2023 and held it in 2 quarters. The position peaked at $764K in Q3 2023. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

Y-Intercept (HK) reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
Y-Intercept (HK) sold 5,091 Axcelis shares in Q1 2024, an estimated $660K.
Y-Intercept (HK) first reported a position in Axcelis in Q3 2023 and held it in 2 quarters.
Y-Intercept (HK)'s Axcelis position peaked at $764K in Q3 2023.
385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Y-Intercept (HK)'s 13F filing for Q1 2024, filed 10 May 2024.